Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-07-19

Clinical Trial Update: T-regulatory Cells in Diabetic Type Two Nephropathy

View source ↗

Summary

This entry reports an ongoing clinical trial investigating regulatory T cells as a treatment for diabetic nephropathy in type 2 diabetes, with the current statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Assiut University | Conditions: Diabetic Nephropathy Type 2 | Status: UNKNOWN